StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sage Therapeutics (SAGE) PT Lowered to $15 at Stifel
August 1, 2024 6:40 AM
Stifel analyst Paul Matteis lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $15.00 (from $20.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
SAGE Therapeutics (SAGE) Misses Q2 EPS by 6c
July 31, 2024 4:18 PM
Form 10-Q Sage Therapeutics, Inc. For: Jun 30
July 31, 2024 4:16 PM
Form 8-K Sage Therapeutics, Inc. For: Jul 31
July 31, 2024 4:11 PM
Sage Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
July 31, 2024 4:05 PM
TD Cowen Downgrades Sage Therapeutics (SAGE) to Hold
July 30, 2024 5:29 AM
